Dr. Angela Hirbe, M.D., Ph.D.

Claim this profile

Washington University School of Medicine

Studies Head and Neck Cancers
Studies Soft Tissue Sarcoma
4 reported clinical trials
8 drugs studied

Area of expertise

1Head And Neck Cancers
Angela Hirbe, M.D., Ph.D. has run 2 trials for Head and Neck Cancers. Some of their research focus areas include:
MTAP positive
Stage IV
Stage III
2Soft Tissue Sarcoma
Angela Hirbe, M.D., Ph.D. has run 2 trials for Soft Tissue Sarcoma. Some of their research focus areas include:
Stage IV

Affiliated Hospitals

Image of trial facility.
Washington University School Of Medicine
Image of trial facility.
Washington University

Clinical Trials Angela Hirbe, M.D., Ph.D. is currently running

Image of trial facility.

ADI-PEG 20 + Ifosfamide + Radiotherapy

for Soft Tissue Sarcoma

In this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrolling to phase II will be treated at that dose level to assess efficacy.
Recruiting1 award Phase 1 & 2

More about Angela Hirbe, M.D., Ph.D.

Clinical Trial Related5 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Angela Hirbe, M.D., Ph.D. has experience with
  • Circulating Tumor DNA (ctDNA)
  • Cabozantinib
  • Nivolumab
  • Ipilimumab
  • ADI PEG20
  • Ifosfamide
Breakdown of trials Angela Hirbe, M.D., Ph.D. has run
Head and Neck Cancers
Soft Tissue Sarcoma
Lymphoma
Breast Cancer
Genitourinary Cancers

Other Doctors you might be interested in

Justin Barnes, M.D.Washington University School of Medicine
Thomas Maddox, MDWashington University School of Medicine
Benjamin Tan, MDWashington University School of Medicine

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Angela Hirbe, M.D., Ph.D. specialize in?
Angela Hirbe, M.D., Ph.D. focuses on Head and Neck Cancers and Soft Tissue Sarcoma. In particular, much of their work with Head and Neck Cancers has involved MTAP positive patients, or patients who are Stage IV.
Is Angela Hirbe, M.D., Ph.D. currently recruiting for clinical trials?
Yes, Angela Hirbe, M.D., Ph.D. is currently recruiting for 1 clinical trial in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Angela Hirbe, M.D., Ph.D. has studied deeply?
Yes, Angela Hirbe, M.D., Ph.D. has studied treatments such as Circulating Tumor DNA (ctDNA), Cabozantinib, Nivolumab.
What is the best way to schedule an appointment with Angela Hirbe, M.D., Ph.D.?
Apply for one of the trials that Angela Hirbe, M.D., Ph.D. is conducting.
What is the office address of Angela Hirbe, M.D., Ph.D.?
The office of Angela Hirbe, M.D., Ph.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top